Clinical trial

DOuBLED - Doubling Outcomes by Lung Cancer Early Diagnosis

NCT05091437

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-12-30

PhaseN/A

Study timeline

Study start (actual)2021-12-30Date precision: day

Registry last updated2025-09-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Nodulesunresolved

Interventions

Observational studyDIAGNOSTIC_TEST

Sponsors & collaborators

AstraZenecalead sponsor

INCUNA (Scientific and Technical partner)collaborator

Mapped research locations

São PauloBrazil1 Mexico CityMexico1 Rio de JaneiroBrazil1 Porto AlegreBrazil1 MonterreyNuevo León, Mexico1 BogotáColombia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05091437 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.